H. Struikmans

10.5k total citations · 2 hit papers
132 papers, 5.6k citations indexed

About

H. Struikmans is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, H. Struikmans has authored 132 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Cancer Research, 56 papers in Oncology and 39 papers in Pathology and Forensic Medicine. Recurrent topics in H. Struikmans's work include Breast Cancer Treatment Studies (80 papers), Breast Lesions and Carcinomas (34 papers) and Advanced Radiotherapy Techniques (28 papers). H. Struikmans is often cited by papers focused on Breast Cancer Treatment Studies (80 papers), Breast Lesions and Carcinomas (34 papers) and Advanced Radiotherapy Techniques (28 papers). H. Struikmans collaborates with scholars based in Netherlands, Belgium and France. H. Struikmans's co-authors include Philip Poortmans, Harry Bartelink, Laurence Collette, Alain Fourquet, J.J. Jager, M. Piérart, W.J. Hoogenraad, Jean-Claude Horiot, Henk B. Kal and Walter Van den Bogaert and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

H. Struikmans

126 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

2007 722 citations Harry Bartelink, Jean-Claude Horiot et al. profile →
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation

2001 693 citations Harry Bartelink, Jean-Claude Horiot et al. profile →

Peers

Countries citing papers authored by H. Struikmans

Since Specialization

Citations

This map shows the geographic impact of H. Struikmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Struikmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Struikmans more than expected).

Fields of papers citing papers by H. Struikmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Struikmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Struikmans. The network helps show where H. Struikmans may publish in the future.

Co-authorship network of co-authors of H. Struikmans

This figure shows the co-authorship network connecting the top 25 collaborators of H. Struikmans. A scholar is included among the top collaborators of H. Struikmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Struikmans. H. Struikmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deintensification of Radiotherapy Use in Treatment of Ductal Carcinoma In Situ in the Netherlands–A Nationwide Overview From 2008 Until 2022 2024 ·Clinical Oncology ·(unknown), Maurice J.C. van der Sangen, Marissa C. van Maaren, John H. Maduro, Luc J. A. Strobbe, Mieke J. Aarts, (unknown), Jelle Wesseling, (unknown), H. Struikmans, Sabine Siesling	0
2	Trends and variations in treatment of stage I–III non-small cell lung cancer from 2008 to 2018: A nationwide population-based study from the Netherlands 2021 ·Lung Cancer ·(unknown), Katrien De Jaeger, Lizza Hendriks, Maurice J.C. van der Sangen, Chris H.J. Terhaard, Sabine Siesling, Dirk De Ruysscher, H. Struikmans, Mieke J. Aarts	22
3	Impaired Geriatric 8 Score is Associated with Worse Survival after Radiotherapy in Older Patients with Cancer 2020 ·Clinical Oncology ·(unknown), Rutger A. Middelburg, (unknown), M. Mast, (unknown), Jan J. Jobsen, Tom Rozema, Huub Maas, Elisabeth D. Geijsen, (unknown), (unknown), J. Van Loon, Tom Budiharto, Mieke J. Aarts, (unknown), H. Struikmans	8
4	An actualised population‐based study on the use of radiotherapy in breast cancer patients in the Netherlands 2019 ·The Breast Journal ·K. Schreuder, (unknown), Mieke J. Aarts, J. W. S. Merkus, Philip Poortmans, Jan J. Jobsen, Sabine Siesling, H. Struikmans	10
5	Variation in the Use of Boost Irradiation in Breast-Conserving Therapy in the Netherlands: The Effect of a National Guideline and Cofounding Factors 2018 ·Clinical Oncology ·K. Schreuder, John H. Maduro, P.E.R. Spronk, Nina Bijker, Philip Poortmans, Thijs van Dalen, H. Struikmans, Sabine Siesling	12
6	Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients 2014 ·Breast Cancer Research and Treatment ·M. Mast, (unknown), (unknown), (unknown), Mark W. Heijenbrok, Eugen B. Hug, (unknown), (unknown), Erik W. Korevaar, Hans Paul van der Laan, Johannes A. Langendijk, (unknown), A. Petoukhova, Jacobus Maarten Schippers, H. Struikmans, John H. Maduro	69
7	Timing of radiotherapy in breast-conserving therapy: a large prospective cohort study of node-negative breast cancer patients without adjuvant systemic therapy 2013 ·British Journal of Cancer ·Jan J. Jobsen, Job van der Palen, Michael Baum, Mariël Brinkhuis, H. Struikmans	18
8	Long-term cosmetic changes after breast-conserving treatment of patients with stage I–II breast cancer and included in the EORTC ‘boost versus no boost’ trial 2012 ·Annals of Oncology ·(unknown), Hein Putter, Harry Bartelink, Jaime S. Cardoso, Maria João Cardoso, (unknown), Evert M. Noordijk, Philip Poortmans, C.C. Rodenhuis, H. Struikmans	63
9	Dose–effect relation in stereotactic radiotherapy for brain metastases. A systematic review 2011 ·Radiotherapy and Oncology ·Ruud Wiggenraad, Antoinette Verbeek-de Kanter, Henk B. Kal, Martin Klein, Thomas Vissers, H. Struikmans	138
10	Magnetic Resonance Imaging– Versus Computed Tomography–Based Target Volume Delineation of the Glandular Breast Tissue (Clinical Target Volume Breast) in Breast-Conserving Therapy: An Exploratory Study 2010 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), E. Kouwenhoven, Astrid N. Scholten, Emile G. Coerkamp, Mark W. Heijenbrok, W. Jansen, M. Mast, A. Petoukhova, H. Struikmans	31
11	Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925) 2010 ·Acta Oncologica ·Oscar Matzinger, (unknown), Philip Poortmans, Laurence Collette, H. Struikmans, Walter Van den Bogaert, Alain Fourquet, Harry Bartelink, (unknown), Ákos Gulybán, M. Piérart, Geertjan van Tienhoven, (unknown), (unknown)	91
12	Measuring the similarity of target volume delineations independent of the number of observers 2009 ·Physics in Medicine and Biology ·E. Kouwenhoven, (unknown), H. Struikmans	108
13	Surgical stress and accelerated tumor growth. 2008 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Henk B. Kal, H. Struikmans, (unknown)	3
14	Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’ 2008 ·European Journal of Cancer ·Sandra Collette, Laurence Collette, Tom Budiharto, Jean-Claude Horiot, Philip Poortmans, H. Struikmans, Walter Van den Bogaert, Alain Fourquet, J.J. Jager, W.J. Hoogenraad, Rolf‐Peter Mueller, John M. Kurtz, D.A.L. Morgan, Jean‐Bernard Dubois, E. Salamon, R.O. Mirimanoff, M. Bolla, (unknown), Carla C. Wárlám-Rodenhuis, Harry Bartelink	157
15	The Impact of Boost Dose and Margins on the Local Recurrence Rate in Breast Conserving Therapy: Results From the EORTC Boost-No Boost Trial 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Helen Jones, Ninja Antonini, (unknown), Alain Fourquet, W.J. Hoogenraad, W. Van den Bogaert, J.J. Jager, P. Poortmans, H. Struikmans, Harry Bartelink	6
16	Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes 2007 ·European Journal of Cancer ·E. Musat, Philip Poortmans, Walter Van den Bogaert, H. Struikmans, Alain Fourquet, Harry Bartelink, Carine Kirkove, Volker Budach, M. Piérart, Laurence Collette	24
17	CBO-richtlijn 'behandeling van het mammacarcinoom' 2002 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Emiel J. Rutgers, J.W.R. Nortier, M.K. Tuut, Geertjan van Tienhoven, H. Struikmans, M. Bontenbal, M.F. von Meyenfeldt, Gerard Vreugdenhil, (unknown), Bert Garssen, J.L. Peterse	38
18	Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study 2002 ·The Lancet ·Martin Klein, J. J. Heimans, N.K. Aaronson, (unknown), (unknown), Martin J. Muller, T.J. Postma, (unknown), (unknown), (unknown), GJ Ossenkoppele, GW van Imhoff, AW Dekker, Jelle Jolles, Ben J. Slotman, H. Struikmans, M. J. B. Taphoorn	454
19	Proliferative capacity in head and neck cancer 2001 ·Head & Neck ·H. Struikmans, Henk B. Kal, (unknown), Ingeborg van der Tweel	10
20	Prophylactic cranial irradiation in limited disease small-cell lung cancer in complete remission: a retrospective analysis 2001 ·Respiratory Medicine ·Yvette M. van der Linden, (unknown), Ingeborg van der Tweel, R.G.J.R.A. Vanderschueren, N.J.J. Schlösser, J.-W.J. Lammers, H. Struikmans	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact